Induction of membrane-type matrix metalloproteinase-1 stimulates angiogenic activities of bovine aortic endothelial cells

Angiogenesis

Volumn 3, Issue 2, 1999, Pages 167-174

  Jeong, Joo Won ^a   Cha, Hee Jae ^b,c   Yu, Dae Yeul ^d   Seiki, Motoharu ^c   Kim, Kyu Won ^a,b  

^a Department of Molecular Biology ^*  (South Korea)

^b Pusan National University   (South Korea)

^c UNIVERSITY OF TOKYO   (Japan)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Angiogenesis; Bovine aortic endothelial cells; MMP 2; MT1 MMP

Indexed keywords

BOVINAE;

EID: 0008135368     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009065709676     Document Type: Article

References (32)

1. Sage EH. Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol 1997; 7: 182-86.
2. Reich E. Tumor-associated fibrinolysis. In Clarkson B, Baserga R (eds): Control of Proliferation of Animal Cells. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory 1974; 351-65.
3. McAuslan BR, Hoffman H. Endothelium stimulating factor from Walker carcinoma cells. Exp Cell Res 1979; 192: 574-80.
4. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267(16): 10931-4.
5. Bischoff J. Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol 1995; 5: 69-73.
6. Sato H, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 1996; 119: 209-15.
7. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-54.
8. Deryugina EI, Bourdon MA, Luo GX et al. Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 1997; 110: 2473-82.
9. Emonard HP, Remacle AG, Noel AC et al. Tumor cell surface-associated binding site for the Mr 72000 type IV collagenase. Cancer Res 1992; 52: 5845-48.
10. Nagase H. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res 1998; 8: 179-86.
11. Butler GS, Butler MJ, Atkinson SL et al. The TIMP-2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. J Biol Chem 1998; 273: 871-80.
12. Cao J, Sato H, Takino T, Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 1995; 270(2): 801-5.
13. Jones JL, Walker RA. Control of matrix metalloproteinase activity in cancer. J Pathol 1997; 183: 377-9.
14. Haas TL, Davis SJ, Madri JA. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 1998; 273(6): 3604-10.
15. Wigler M, Pellicer A, Silverstein S et al. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci USA 1979; 76(3): 1373-6.
16. Lohi J, Lehti K, Westermarck JK et al. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 1996; 239: 239-47.
17. Richards RG, DiAugustine RP, Petrusz P et al. Estradiol stimulates tyrosine phosphrylation of the insulin-like growth factor-I receptor and insulin receptor substrate-I in the uterus. Proc Natl Acad Sci USA 1996; 93: 12002-7.
18. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-5.
19. Towin HT, Stehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
20. Herron GS, Werb Z, Dwyer K, Banda MJ. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 1986; 261: 2814-9.
21. Saiki I, Fujii H, Yoneda J et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1983; 54: 137-43.
22. Shinji Y, Peter RN, Kent KC. Role of protein kinase C in attachment, spreading, and migration of human endothelial cells. J Surg Res 1996; 63: 349-54.
23. Cha HJ, Bae SK, Lee HY et al. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res 1996; 56: 2281-4.
24. Cha HJ, Park MT, Chung HY et al. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells. Oncogene 1998; 16: 771-8.
25. Ito A, Yamada M, Sato T et al. Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts. Eur J Biochem 1998; 251: 353-8.
26. Senger DR. Molecular framework for angiogenesis. Am J Pathol 1996; 149: 1-7.
27. Romer J, Bugge TH, Pyke C et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996; 2: 287-92.
28. Carmeliet P, Moons L, Dewerchin M et al. Receptor-independent role of urokinase-typeplasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J Cell Biol 1998; 140: 233-45.
29. Chapman HA. Plasminogen activators, integrins and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997; 9: 714-24.
30. Werb Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell 1997; 91: 439-42.
31. Maquoi E, Noel A, Frankenne F et al. Inhibition of matrix metalloproteinase-2 maturation and HT1080 invasiveness by a synaptic furin inhibitor. FEBS Lett 1998; 424: 262-6.
32. Hiraoka N, Allen E, Apel IJ et al. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998; 95: 365-77.